About us

ABOUT

StatuManu ICP Aps is a Danish medical device start-up. StatuManu ICP is developing a software as a service medical device, based on deep learning methods, for non-invasive measurement and monitoring of intracranial pressure.

WHY?

Since the 1920s, scientists have worked on developing methods for measuring the pressure in the brain without having to drill a hole in the cranium. Here, the identification of the causes for increased pressure is important for diagnosing the condition and treating the pressure. StatuManu ICP will provide a service not yet present in the market of ICP monitoring. As a non-invasive solution, the ICP Tracker eliminates critical risks associated with current methods, beneficial for both patients and society. 

BACKGROUND

StatuManu was founded in 2015 and now consists of six employees. We continue to work with the development of the software solution until we are able to help solve the clinical need for non-invasive measurement of ICP. As a company, StatuManu ICP’s mission is to save brain to save lives by enabling fast, reliable and non-invasive assessment of ICP, and being positioned as the standard tool for ICP monitoring. 

THE GOAL

The valuable contribution of ICP Tracker is evident as symptoms of elevated ICP often mimic those of other less dangerous illnesses. The goal is that non-invasive methods to detect possible changes in ICP will be used in all instances of suspected elevated ICP.

SOLVING A WELL-DEFINED CLINICAL NEED

StatuManu ICP Aps is a Danish medical device start-up. StatuManu ICP is developing a software as a service medical device, based on deep learning methods, for non-invasive measurement and monitoring of intracranial pressure.

Since the 1920s, scientists have worked on developing methods for measuring the pressure in the brain without having to drill a hole in the cranium. Here, the identification of the causes for increased pressure is important for diagnosing the condition and treating the pressure. StatuManu ICP will provide a service not yet present in the market of ICP monitoring. As a non-invasive solution, the ICP Tracker eliminates critical risks associated with current methods, beneficial for both patients and society.

Meet the team

Ja-2

Jakob Find Madsen

CEO and Founder

Ka-2

Kathrine Céline Friis

Administration and Communications Manager

Ma

Mathilde Birn

Business Development Manager

awaiting

Frederik Drachmann

Lead Software Developer

Jo-2

Jonas Rossing

Data Manager

awaiting

Adrian Atienza

Software Developer

awaiting

Alberte Riber Jakobsen

Student Assistant

Ja-2.jpg

Jakob Find Madsen

CEO and Founder

Ka-2.jpg

Kathrine Céline Friis

Administration and Communications Manager

Ma.jpg

Mathilde Birn

Business Development Manager

image009.png

Frederik Drachmann

Lead Software Developer

Jo-2.jpg

Jonas Rossing

Data Manager

image009.png

Adrian Atienza

Software Developer

image009.png

Alberte Riber Jakobsen

Student Assistant

Tidligere
Næste
JAKOB FIND MADSEN
CEO AND FOUNDER
KATHRINE CÉLINE FRIIS
ADMINISTRATION AND COMMUNICATIONS MANAGER
MATHILDE BIRN
BUSINESS DEVELOPMENT MANAGER
FREDERIK DRACHMANN
LEAD SOFTWARE DEVELOPER
JONAS ROSSING
DATA MANAGER
ADRIAN ATIENZA
SOFTWARE DEVELOPER
ALBERTE RIBER JAKOBSEN
STUDENT ASSISTANT
Tidligere
Næste
Scroll til toppen